Results 181 to 190 of about 57,164 (280)

Toward Secure Supply of Remdesivir via a 2-Pot Triazine Synthesis: Supply Centered Synthesis [PDF]

, 2020
Dinesh J. Paymode, Flavio S. P. Cardoso, Joshua D. Sieber, John W. Tomlin, Daniel W. Cook, Justina M. Burns, Rodger W. Stringham, B. Frank Gupton, David R. Snead, Toolika Agrawal   +9 more
openalex   +1 more source

Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019 [PDF]

, 2020
Richard M. Burwick, Sigal Yawetz, Kathryn E. Stephenson, Ai‐ris Y. Collier, Pritha Sen, Brian G. Blackburn, Erna Milunka Kojic, Adi Hirshberg, José Francisco Suárez, Magdalena E. Sobieszczyk, Kristen Marks, Shawn Mazur, Cecilia Big, Oriol Manuel, Gregory Morlin, Suzanne J. Rose, Mariam Naqvi, Ilona T. Goldfarb, Adam DeZure, Laura Telep, Susanna K. Tan, Yang Zhao, Tom Hahambis, Jason Hindman, Anand P. Chokkalingam, Christoph C Carter, Moupali Das, Anu Osinusi, Diana M. Brainard, Tilly Varughese, Olga Kovalenko, Matthew Sims, Samit Desai, Geeta K. Swamy, Jeanne S. Sheffield, Rebecca Zash, William R. Short   +36 more
openalex   +1 more source

Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase

, 2019
Ariane J. Brown, John J. Won, Rachel L. Graham, Kenneth H. Dinnon, Amy Sims, Joy Y. Feng, Tomáš Cihlář, Mark R. Denison, Ralph S. Baric, Timothy P. Sheahan   +9 more
openalex   +2 more sources

Covid-19: What now for remdesivir?

, 2020
Jeremy Hsu
openalex   +1 more source

Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro

Antiviral Research, 2020
Ka-Tim Choy, Alvina Y. L. Wong, P. Kaewpreedee, S. Sia, Dongdong Chen, K. P. Hui, D. K. Chu, M. Chan, P. Cheung, Xuhui Huang, M. Peiris, H. Yen   +11 more
semanticscholar   +1 more source

Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven

Contemporary Clinical Trials Communications, 2020
From December 2019 to May 22, 2020 the emerging and ever-increasing pandemic of coronavirus 19 (COVID-19) had no effective and safe treatment. Not surprisingly, remdesivir attracted worldwide attention. In a trial published online ahead of print, of 1063
Richard D. Shih, Dennis G. Maki, Charles H. Hennekens   +2 more
doaj  

Remdesivir—Bringing Hope for COVID-19 Treatment [PDF]

, 2020
Naser F. Al‐Tannak, Ladislav Novotný, Adel Al‐Hunayan   +2 more
openalex   +1 more source

Use of dexamethasone, remdesivir, convalescent plasma and prone positioning in the treatment of severe COVID-19 infection in pregnancy: A case report

, 2020
Jennifer Jacobson, Kathleen M. Antony, Michael Beninati, William T. Alward, Kara K. Hoppe   +4 more
openalex   +1 more source

A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19 [PDF]

, 2020
Dawid Maciorowski, Samir Z. El Idrissi, Yash Gupta, Brian Medernach, Michael B. Burns, Daniel P. Becker, Ravi Durvasula, Prakasha Kempaiah   +7 more
openalex   +1 more source

A Chemoenzymatic Synthesis of the (R_P)-Isomer of the Antiviral Prodrug Remdesivir

, 2020
Andrew N. Bigley, Tamari Narindoshvili, Frank M. Raushel   +2 more
openalex   +2 more sources